Compare Adaptive Biotechnologies Corp (ADPT) vs United States Brent Oil Fund LP (BNO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs United States Brent Oil Fund LP — how do they compare? Adaptive Biotechnologies Corp trades at $20.06 (market cap $3.33B), while United States Brent Oil Fund LP trades at $43.4. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.
| ADPT | BNO | |
|---|---|---|
Market Cap | $3.33B | — |
Sector | Health | Commodities - Energy |
52-Week High | $22.37 | $60.13 |
52-Week Low | $10.24 | $27.20 |
Enterprise Value | $3.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
BNO trades at $39.94, up 0.68% on the day, amid a bearish technical backdrop with moving averages signaling caution and oscillators neutral. Recent news highlights oil price volatility driven by Middle East tensions and supply disruptions, though fundamental financial ratios are unavailable. The stock faces resistance near $40 with support at $39.
The outlook remains clouded by geopolitical risks and oil market volatility, with limited fundamental data. Upside depends on sustained oil price recovery, but downside risks from supply surges or demand weakness persist. Investors should weigh technical bearishness against external catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →
